sansert has been researched along with Bilateral Headache in 2 studies
1-methyllysergic acid butanolamide: RN given refers to parent cpd(8beta)-isomer
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
GRAHAM, JR | 1 |
DOMINGUEZ LAZARO, AR | 1 |
SASTRE CASTILLO, A | 1 |
PEREZ GUERRERO, J | 1 |
CALLEJA CANELAS, JL | 1 |
2 other studies available for sansert and Bilateral Headache
Article | Year |
---|---|
Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.
Topics: Biomedical Research; Headache; Lysergic Acid; Lysergic Acid Diethylamide; Methysergide | 1960 |
[UML-491 (1-methyl-D-lysergic acid butanolamide) in the prevention and treatment of migraine and other types of headache].
Topics: Biomedical Research; Headache; Lysergic Acid; Lysergic Acid Diethylamide; Methysergide; Migraine Dis | 1962 |